Caris Life Sciences vs Nona Biosciences
Caris Life Sciences vs Nona Biosciences, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and Nona Biosciences on 62/100.
Where each one leads
Caris Life Sciences
- agent readiness: 47/100 against 40/100
- domain rating: 62/100 against 32/100
- headcount: 1,659 against 82
- LinkedIn following: 77,698 against 15,487
Nona Biosciences
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Caris Life Sciences | Nona Biosciences |
|---|---|---|
| What it is | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. | Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Drug Discovery, Antibody Discovery, Therapeutics Development |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2008 | 2021 |
| Headquarters | Irving, United States | Shanghai, China |
| Status | Active | Active |
Size, funding and growth
| Measure | Caris Life Sciences | Nona Biosciences |
|---|---|---|
| Employees | 1,659 | 82 |
| Headcount growthLast 12 months | Not published | +115.0% |
| Total funding | $700M | Not published |
| Latest round | Series D | Not published |
| Valuation | $7.8B | Not published |
| LinkedIn followers | 77,698 | 15,487 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Caris Life Sciences | Nona Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 62/100 |
| Traction | 60/100 | Not published |
| Team | Not published | 36/100 |
| Search visibility | 22/100 | 75/100 |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 62/100 | 32/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Caris Life Sciences | Nona Biosciences |
|---|---|---|
| Hosting | Self Managed | Google Cloud |
| CMS | WordPress | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4, Google Tag Manager, Microsoft Clarity |
| Support stack | Not detected | HubSpot |
Caris Life Sciences vs Nona Biosciences: common questions
Which is better, Caris Life Sciences or Nona Biosciences?
On our 0-100 score Nona Biosciences rates higher (62/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Caris Life Sciences and Nona Biosciences compare on the numbers?
Caris Life Sciences leads on agent readiness (47/100 against 40/100), domain rating (62/100 against 32/100), headcount (1,659 against 82), LinkedIn following (77,698 against 15,487).
Read the full Caris Life Sciences review and pricing or the Nona Biosciences review and pricing. You can also browse other Caris Life Sciences alternatives we track.